Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary disease induced by methotrexate].

L Gruberg1, A Livneh, J Rozenman

  • 1Dept. of Medicine F, Chaim Sheba Medical Center, Tel Hashomer.

Harefuah
|June 1, 1990
PubMed
Summary

Methotrexate can cause a rare lung disease in rheumatoid arthritis patients, presenting as pneumonia. Early recognition of this methotrexate-induced lung disease is crucial for patient safety and continued treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Honeycomb appearance of fetal myofibromatosis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2018
Same author

Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.

Clinical and experimental immunology·2017
Same author

T helper 17 polarization in familial Mediterranean fever.

Genes and immunity·2013
Same author

Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever.

International journal of immunopathology and pharmacology·2013
Same author

Exertional muscle pain in familial Mediterranean fever patients evaluated by MRI and 31P magnetic resonance spectroscopy.

Clinical radiology·2012
Same author

Exertional leg pain as a manifestation of occult spondyloarthropathy in familial Mediterranean fever: an MRI evaluation.

Scandinavian journal of rheumatology·2012

Area of Science:

  • Rheumatology
  • Pulmonology
  • Toxicology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Methotrexate is a primary disease-modifying antirheumatic drug (DMARD) for RA.
  • Methotrexate has potential pulmonary toxicity.

Observation:

  • A 68-year-old male RA patient presented with fever, cough, and respiratory distress.
  • Pulmonary infiltrates were observed on imaging.
  • Initial diagnosis was pneumonia.

Findings:

  • The patient was diagnosed with methotrexate-induced lung disease.
  • This highlights a rare but serious adverse effect of methotrexate therapy.
  • Symptoms mimicked common respiratory infections.

Implications:

  • Increased clinical awareness of methotrexate-induced lung disease is essential.
  • Prompt diagnosis and management can prevent severe complications.
  • Maintaining methotrexate's efficacy in RA requires vigilant monitoring for toxicity.

Related Experiment Videos